ERBB2 and breast cancer: We found that only a small proportion (~7%) of patients with T1N0 HER2+ BC treated with lumpectomy and adjuvant HER2-based systemic therapy did not receive adjuvant radiation in a large cohort of patients treated from 2013 to 2015.